Showing results (21-30 of 256) with videos related to

Sort By:
Pageof 26
Current Opinion in Rheumatology|March 24, 2011
Drug-free remission: is it already possible?Marianne van den Broek, Tom W J Huizinga, Ben A C Dijkmans, et al.
Clinical Rheumatology|April 13, 2011
Microvascular function is preserved in newly diagnosed rheumatoid arthritis and low systemic inflammatory activityIzhar C van Eijk, Erik H Serné, Ben A C Dijkmans, et al.
Clinical and Experimental Rheumatology|March 11, 2008
Prevalence of and risk factors for the metabolic syndrome in women with systemic lupus erythematosusI E M Bultink, F Turkstra, M Diamant, et al.
The Netherlands Journal of Medicine|July 19, 2018
Rifampin levels in daily practice: the accuracy of a single measurementT J F Vanbrabant, A C Dijkmans, J den Hartigh, et al.
Annals of the Rheumatic Diseases|August 16, 2005
Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events, disease activity, and organ damage in patients with systemic lupus erythematosusI E M Bultink, T Teerlink, J A Heijst, et al.
Scandinavian Journal of Rheumatology|May 10, 2003
Outcome in adults with juvenile idiopathic arthritis. Comparison of the DUTCH-AIMS2 between JIA and RAL N Bruinooge, R El Moussaoui, E Taal, et al.
The Journal of Rheumatology|July 15, 2003
Efficacy and safety of mesalazine (Salofalk) in an open study of 20 patients with ankylosing spondylitisJ Christiaan van Denderen, Irene van der Horst-Bruinsma, P Dick Bezemer, et al.
Arthritis and Rheumatism|March 31, 2006
Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation productsDiana Wouters, Alexandre E Voskuyl, Esmeralda T H Molenaar, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 27, 2006
[Rheumatic diseases as risk factors for cardiovascular disease]M T Nurmohamed, A E Voskuyl, I E van der Horst-Bruinsma, et al.
Annals of the Rheumatic Diseases|April 14, 2009
Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trialW H Bos, B A C Dijkmans, M Boers, et al.
Pageof 26